Background Mast cells plays critical role in inflammatory diseases, including cardiovascular and metabolic diseases and their associated complications. These cells exert their physiological and pathological activities by releasing granules containing histamine, cytokines, chemokines, and proteases, including mast cell-specific chymases and tryptases Method 70 Type 2 diabetic obese patients attending the Diabetes and Endocrinology clinic in Kasr El Ani hospital compared to 15 healthy controls Results Statistical significant difference between patients and control regarding BMI, glucose,cholesterol, HDL, LDL,tryptase (p<0.001) ,triglycerides(p=0.001) Tryptase statistically correlated with BMI,fastingglucose,A1C,triglycerides(p=0.014,r=0.031)/(p=0.012,r=0.297)/(p<0.001,r=0.862),(p=0.039,r=0.247) Higher mean level of tryptase in patients with diabetic complications mainly in retinopathy (32.32 ng/ml) Conclusion Tryptase participate in the pathogenesis of diabetes mellitus and its complication targeting mast cells as novel therapy for diabetes requires further investigations
Hamdy, N., Salam, R. F., & Mohamed, N. A. E. (2018). Mast cell, a new player in type 2 diabetes. Kasr Al Ainy Medical Journal, 24(2), -. doi: 10.4103/kamj.kamj_18_18
MLA
Nehal Hamdy; Randa F. Salam; Nagwa Abd EL-Ghaffar Mohamed. "Mast cell, a new player in type 2 diabetes", Kasr Al Ainy Medical Journal, 24, 2, 2018, -. doi: 10.4103/kamj.kamj_18_18
HARVARD
Hamdy, N., Salam, R. F., Mohamed, N. A. E. (2018). 'Mast cell, a new player in type 2 diabetes', Kasr Al Ainy Medical Journal, 24(2), pp. -. doi: 10.4103/kamj.kamj_18_18
VANCOUVER
Hamdy, N., Salam, R. F., Mohamed, N. A. E. Mast cell, a new player in type 2 diabetes. Kasr Al Ainy Medical Journal, 2018; 24(2): -. doi: 10.4103/kamj.kamj_18_18